A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 419.3 KBAnacor Pharmaceuticals, Inc.Apr 28, 8:37 PM ET·0001209191-15-036806
- 45.1 KBAnacor Pharmaceuticals, Inc.Jan 6, 4:27 PM ET·0001209191-15-002196
- 45.0 KBAnacor Pharmaceuticals, Inc.Jan 6, 4:25 PM ET·0001209191-15-002191
- SC 13G8.4 KBAnacor Pharmaceuticals, Inc.Jan 6, 1:35 PM ET·0000790502-15-000008
- 45.6 KBAnacor Pharmaceuticals, Inc.Feb 10, 7:38 PM ET·0001209191-14-008844
- 48.6 KBAnacor Pharmaceuticals, Inc.Jan 9, 6:27 PM ET·0001209191-14-002700
- 46.5 KBAnacor Pharmaceuticals, Inc.Jun 19, 6:43 PM ET·0001209191-13-033044
- 48.1 KBAnacor Pharmaceuticals, Inc.Jun 18, 8:44 PM ET·0001209191-13-032830
- 8-K988.9 KBAnacor Pharmaceuticals IncJan 29, 4:52 PM ET·0001104659-13-005555
- 45.1 KBAnacor Pharmaceuticals IncApr 4, 7:35 PM ET·0001104659-11-018563
Insiders
10- BERNS PAUL LDirector, President and CEO
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Heyman Irwin ASenior VP, Drug Development
- Hove Anders DDirector, 10% Owner
- LESCHLY MARKDirector, 10% Owner
- Maples Kirk RSVP, Program Management
- Markham Richard JDirector
- Parker Geoffrey M.Senior Vice President and CFO
- Plattner Jacob jSenior VP, Research
- RIEFLIN WILLIAM JLDirector
Tickers
No tickers on record
Addresses
business
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
mailing
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
Former Names
- Anacor Pharmaceuticals Inc2013-04-08